These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 11903415)

  • 1. Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients.
    Hermann LS; Kalén J; Katzman P; Lager I; Nilsson A; Norrhamn O; Sartor G; Ugander L
    Diabetes Obes Metab; 2001 Dec; 3(6):428-34. PubMed ID: 11903415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metformin on glycaemic variability in combination with insulin in overweight/obese patients with type 1 diabetes.
    Poh Shean W; Chin Voon T; Long Bidin MBB; Adam NLB
    J R Coll Physicians Edinb; 2023 Jun; 53(2):94-103. PubMed ID: 37154572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data-Driven Cluster Analysis of Oxidative Stress Indexes in relation to Vitamin D Level, Age, and Metabolic Control in Patients with Type 2 Diabetes on Metformin Therapy.
    Cojic MM; Klisic A; Kocic R; Veljkovic A; Kocic G
    Oxid Med Cell Longev; 2021; 2021():7942716. PubMed ID: 34239695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Human Adenovirus 36 on Response to Metformin Monotherapy in Obese Mexican Patients with Type 2 Diabetes: A Prospective Cohort Study.
    Tapia-Rivera JC; Mendoza-Jaramillo HE; González-Villaseñor CO; Ramirez-Flores M; Aguilar-Velazquez JA; López-Quintero A; Pérez-Guerrero EE; Vargas-Rodriguez MLÁ; Gutiérrez-Hurtado IA; Martínez-López E
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin adjunct therapy on cardiometabolic parameters in Indian adolescents with type 1 diabetes: a randomized controlled trial.
    Mondkar S; Khandagale S; Shah N; Khadilkar A; Oza C; Bhor S; Gondhalekar K; Wagle A; Kajale N; Khadilkar V
    Front Clin Diabetes Healthc; 2024; 5():1353279. PubMed ID: 38706949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention.
    Moens de Hase E; Neyrinck AM; Rodriguez J; Cnop M; Paquot N; Thissen JP; Xu Y; Beloqui A; Bindels LB; Delzenne NM; Van Hul M; Cani PD
    Diabetologia; 2024 Feb; 67(2):333-345. PubMed ID: 37897566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency.
    Randhawa FA; Mustafa S; Khan DM; Hamid S
    Pak J Med Sci; 2017; 33(4):881-885. PubMed ID: 29067058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Metformin on Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu W; Yang XJ
    Int J Endocrinol; 2016; 2016():3854071. PubMed ID: 27478438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism.
    Miceli DD; Vidal PN; Batter MFC; Pignataro O; Castillo VA
    Open Vet J; 2018; 8(2):193-199. PubMed ID: 29911024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation.
    Ochi T; de Vos S; Touw D; Denig P; Feenstra T; Hak E
    J Diabetes Res; 2024; 2024():7922486. PubMed ID: 38288388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure reactions to insulin treatment in patients with type 2 diabetes.
    Persson SU
    Int J Angiol; 2007; 16(4):135-8. PubMed ID: 22477329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index.
    Ismail HM; Barua S; Wang J; Sabharwal A; Libman I; Bacha F; Nadeau KJ; Tosur M; Redondo MJ
    Diabetes Obes Metab; 2023 Nov; 25(11):3420-3423. PubMed ID: 37485878
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
    Kooy A; de Jager J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
    Arch Intern Med; 2009 Mar; 169(6):616-25. PubMed ID: 19307526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis.
    Szymczak-Pajor I; Drzewoski J; Wenclewska S; Śliwińska A
    Pharmaceuticals (Basel); 2024 Jul; 17(7):. PubMed ID: 39065748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide.
    Matić A; Vuković R; Heffer M; Balog M; Ivić V; Gaspar R; Ducza E; Szucs KF; Seres A; Vari SG; Drenjančević I
    Croat Med J; 2021 Jun; 62(3):215-226. PubMed ID: 34212558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus.
    Li T; Providencia R; Mu N; Yin Y; Chen M; Wang Y; Liu M; Yu L; Gu C; Ma H
    Cardiovasc Diabetol; 2021 Jan; 20(1):30. PubMed ID: 33516224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus.
    Lin C; Cai X; Yang W; Lv F; Nie L; Ji L
    BMC Med; 2020 Nov; 18(1):322. PubMed ID: 33190640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.
    Madsen KS; Kähler P; Kähler LKA; Madsbad S; Gnesin F; Metzendorf MI; Richter B; Hemmingsen B
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012368. PubMed ID: 30998259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review.
    Abdi H; Azizi F; Amouzegar A
    Int J Endocrinol Metab; 2018 Apr; 16(2):e65600. PubMed ID: 30008760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis.
    Yang W; Cai X; Gao X; Chen Y; Chen L; Ji L
    J Diabetes Investig; 2018 Jul; 9(4):813-821. PubMed ID: 29047219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.